Innovative lung cancer drug approved in UAE

www.lumakras.com

The UAE has become the second country in the world to approve the new lung cancer drug 'Lumakras'.

The Ministry of Health and Prevention (MoHAP) has cleared the registration and use of the drug, which recently received the approval of the US Food and Drug Administration (FDA).

It will help speed up the treatment plan of patients in the UAE and improve their quality of life.

Lumakras, manufactured by Amgen, is prescribed to adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), who have received at least one previous cancer therapy.

It is supplied as film-coated tablets for oral use containing 120 mg of sotorasib.

More from Local

Coming Up on Dubai Eye

  • The Best of Dubai Eye 103.8

    7:00am - Noon

    Hear the highlights from the week gone by on Dubai Eye 103.8. Listen again to the best interviews, advice and the top stories that has gripped our conversation this week.

  • The Best of Dubai Eye 103.8

    Noon - 4:00pm

    Hear the highlights from the week gone by on Dubai Eye 103.8. Listen again to the best interviews, advice and the top stories that has gripped our conversation this week.

BUSINESS BREAKFAST LATEST

On Dubai Eye